The FDA has issued a recall of nearly 1 million bottles of Corlanor, a heart failure medication also known by its generic name ivabradine. The recall is due to the presence of a foreign substance on the tablets, which may pose a risk to patients taking the medication.
"The FDA is committed to ensuring the safety and quality of medications," said an FDA spokesperson. The recall affects patients in the Buffalo area who are taking Corlanor to manage their heart condition.
Patients are advised to consult their doctor or pharmacist to determine the best course of action. The recall is a precautionary measure to protect public health. Kaleida Health and other local healthcare providers are working to notify patients who may be affected by the recall. As the recall continues, patients can expect to receive updates from their healthcare providers and the FDA.
The FDA will continue to monitor the situation and provide updates as necessary. The recall is a reminder of the importance of vigilance in ensuring the safety of medications. Patients can report any adverse reactions to the FDA.